Cerebras Heads Into Earnings With a $25 Billion Backlog and a Cloud of Risk

With $25B order backlog, Cerebras faces earnings test amid high volatility, revenue concentration, and margin challenges. Analysts are bullish with price targets up to $300.

The first earnings report since Cerebras Systems went public is just days away, and the numbers Wall Street will be watching most closely have nothing to do with the bottom line. The chip developer is sitting on an order backlog worth nearly $25 billion — a staggering figure that will determine whether the stock's current valuation holds up. The question is how quickly those orders turn into actual revenue.

Investors showed their optimism on Friday, pushing the shares to a close of $236.40 after a volatile session that saw the price swing nearly $30. The jump came after the expiration of the post-IPO lockup period triggered a wave of bullish analyst notes. Ten analysts now peg the average price target at $294, with UBS and Mizuho both calling for $300, Barclays at $280, TD Cowen at $275, and Morgan Stanley at $250. Yet despite the rally, the stock remains 39% below the all-time high of over $386 it hit in May.

That gulf reflects an extreme level of uncertainty. The stock’s annualized volatility exceeds 244%, and the path to justifying a valuation of 90 times trailing sales is narrow. For the first quarter of fiscal 2026, analysts expect revenue of roughly $57 million and a net loss of $0.14 per share. The real focus, however, will be on how quickly Cerebras can convert its massive order book into billable contracts.

The biggest piece of that backlog is a multi-year agreement with OpenAI worth more than $20 billion. Additional partnerships with Amazon Web Services, Meta, and IBM round out the pipeline. Cerebras also holds net liquidity of approximately $846 million, a cushion that gives it room to scale production. Last year, the company achieved an operating turnaround, with revenue jumping 76% to $510 million and net income swinging to $88 million from a large loss the prior year.

But the revenue concentration remains a serious vulnerability. In the prior fiscal year, 86% of sales came from just two customers in the United Arab Emirates. After a U.S. regulatory probe, Cerebras replaced those accounts with OpenAI and AWS — effectively shifting the risk rather than eliminating it. A strategic shift at either partner would hit Cerebras's income statement directly.

Compounding the worry is the margin picture. Gross margins have slipped to 39%, partly because Cerebras builds enormous wafer-scale chips that are far more complex and defect-prone than conventional processors. To support its current valuation, the company must demonstrate that it can stabilize and eventually expand those margins. Competition is also heating up: Nvidia recently acquired the startup Groq for $20 billion, a move that takes direct aim at Cerebras's advantage in fast inference workloads.

The consensus on Wall Street remains optimistic, with every major bank issuing a buy-equivalent rating. But the first earnings call will test whether that faith is warranted. For Cerebras, the imperative is clear: land new enterprise customers from Europe and the U.S., broaden the revenue base, and prove that the $25 billion backlog is more than a stack of promises. Without those steps, the stock’s lofty multiple will rest on shaky ground.